News/Press

Medical Need gains rights to product for the treatment of progressive multiple sclerosis (MS) Medical Need announced today that it has entered into an exclusive

New EU orphan drug designation for the treatment of Congenital Sucrase-Isomaltase Deficiency Medical Need Europe AB earlier announced that the European Commission has approved the

EU Marketing Authorization for the treatment of Urea Cycle Disorders Medical Need announced today that the European Commission on July 31, 2013, issued a marketing

Medical Need and CTD Holdings enter into a partnership for treatment of Niemann-Pick Type C disease Medical Need today announced that it has entered into

Medical Need announced today that it has entered into an exclusive distribution agreement with the Italian company ADIENNE Pharma & Biotech relating to their product

Medical Need announced today that it has entered into an exclusive distribution agreement with German company Hennig Arzneimittel relating to their product Arlevert® in the

The SME status qualify Medical Need to benefit from the provisions for administrative and financial assistance for SMEs laid down in Regulation (EC) No 2049/2005.